Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022

Effectiveness against severe COVID-19 of a second booster dose of the bivalent (original/BA.4–5) mRNA vaccine 7–90 days post-administration, relative to a first booster dose of an mRNA vaccine received ≥ 120 days earlier, was ca 60% both in persons ≥ 60 years never infected and in those infected >...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabiani, Massimo, Mateo-Urdiales, Alberto, Sacco, Chiara, Fotakis, Emmanouil Alexandros, Rota, Maria Cristina, Petrone, Daniele, Bressi, Marco, Del Manso, Martina, Siddu, Andrea, Fedele, Giorgio, Stefanelli, Paola, Bella, Antonino, Riccardo, Flavia, Palamara, Anna Teresa, Rezza, Giovanni, Brusaferro, Silvio, Pezzotti, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951255/
https://www.ncbi.nlm.nih.gov/pubmed/36820640
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.8.2300105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951255/
https://www.ncbi.nlm.nih.gov/pubmed/36820640
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.8.2300105

Ejemplares similares